1910 GENETICS
Biotechnology, 245 1st St, Cambridge, Massachusetts, 02142, United States, 11-50 Employees
Phone Number: +18*********
Who is 1910 GENETICS
We are a biotechnology company integrating AI, computation and biological automation to accelerate the design of small molecule and protein therapeutics. Our mission is to decrease the ti...
Read More
-
Headquarters: 245 1st St, Cambridge, Massachusetts, 02142, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: 5 Million to 10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541713 |
Show More
Does something look wrong? Fix it. | View contact records from 1910 GENETICS
View Employees
Email
Phone
Similar Companies to 1910 Genetics
Biotheryx
-
11-50
-
$ 5 Million to 10 Million
1910 Genetics Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding 1910 Genetics
Answer: 1910 Genetics's headquarters are located at 245 1st St, Cambridge, Massachusetts, 02142, United States
Answer: 1910 Genetics's phone number is +18*********
Answer: 1910 Genetics's official website is https://1910genetics.com
Answer: 1910 Genetics's revenue is 5 Million to 10 Million
Answer: 1910 Genetics's SIC: 8731
Answer: 1910 Genetics's NAICS: 541713
Answer: 1910 Genetics has 11-50 employees
Answer: 1910 Genetics is in BIOTECHNOLOGY
Answer: 1910 Genetics top competitors include: Fluent Biosciences, Calviri, Biotheryx, Unum Therapeutics, Ixcela, Tensixteen Bio, Oncoc4, Singlera Genomics, Ubivac, Cambrian Biopharma, Dyadic International
Answer: 1910 Genetics contact info: Phone number: +18********* Website: https://1910genetics.com
Answer: We are a biotechnology company integrating AI, computation and biological automation to accelerate the design of small molecule and protein therapeutics. Our mission is to decrease the timeline and cost of drug development, while improving the success rate of bring innovative medicines to patients in need. We have two drug discovery engines - ELVIS™ and ROSALYND™ - that enable the design of both small molecule and protein therapeutics, an unmatched capability in the AI drug discovery space. Our therapeutic area-agnostic, end-to-end technology powers the full length of early drug discovery - from novel hit discovery to hit to lead, and lead optimization. We are currently applying our technology to drug discovery programs in several areas including, but not limited to, neuroscience, infectious disease, immunology and oncology.
Answer:
Premium Sales Data for Prospecting
- Sales data across over 200M records
- Up-to-date records (less decayed data)
- Accurate Email Lists (real-world tested)
- Powerful search engine and intuitive interface
Get Full Access
View Employees
1910 Genetics Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month